TipRanks
Advertisement
Advertisement

KZR Stock Latest News

Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors
Company AnnouncementsKezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors
5M ago
KZR
Kezar Life Sciences Acquired by Aurinia, Delisted From Nasdaq
PremiumCompany Announcements
Kezar Life Sciences Acquired by Aurinia, Delisted From Nasdaq
5M ago
8K
KZR
Kezar Life Sciences Announces Major Executive Leadership Changes
PremiumCompany Announcements
Kezar Life Sciences Announces Major Executive Leadership Changes
6M ago
8K
KZR
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
PremiumThe Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
6M ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
6M ago
IQ
SR
Kezar Life Sciences to Be Acquired by Aurinia
PremiumCompany AnnouncementsKezar Life Sciences to Be Acquired by Aurinia
6M ago
8K
KZR
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
7M ago
KZR
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
7M ago
KZR
AUPH
Kezar Divests Sec61 Program to Refocus on Core Pipeline
PremiumCompany Announcements
Kezar Divests Sec61 Program to Refocus on Core Pipeline
7M ago
8K
KZR
KZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
KZR
Kezar Life Sciences: FDA grants Type C meeting to discuss zetomipzomib
PremiumThe Fly
Kezar Life Sciences: FDA grants Type C meeting to discuss zetomipzomib
9M ago
KZR
Kezar Life Sciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Kezar Life Sciences Reports Q3 2025 Financial Results
11M ago
KZR
Kezar Life Sciences reports Q3 EPS ($1.53), consensus ($1.96)
PremiumThe FlyKezar Life Sciences reports Q3 EPS ($1.53), consensus ($1.96)
11M ago
KZR
Kezar Life Sciences Announces Major Workforce Reduction
Premium
Company Announcements
Kezar Life Sciences Announces Major Workforce Reduction
11M ago
8K
KZR
Kezar Life Sciences Repays Loan, Ends Agreement
Premium
Company Announcements
Kezar Life Sciences Repays Loan, Ends Agreement
12M ago
8K
KZR
Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
PremiumThe Fly
Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
12M ago
KZR
Kezar downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Kezar downgraded to Market Perform from Outperform at William Blair
12M ago
KZR
Kezar Life Sciences Faces Uncertainty with Hold Rating Amid FDA Setback and Strategic Alternatives Exploration
PremiumRatings
Kezar Life Sciences Faces Uncertainty with Hold Rating Amid FDA Setback and Strategic Alternatives Exploration
12M ago
KZR
Kezar Life Sciences downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Kezar Life Sciences downgraded to Hold from Buy at Jefferies
12M ago
KZR
Closing Bell Movers: CSX gains over 2% on earnings beat; OZK slips on miss
PremiumThe FlyClosing Bell Movers: CSX gains over 2% on earnings beat; OZK slips on miss
12M ago
MU
CFG
Kezar Life Sciences Faces FDA Challenges in Drug Program
Premium
Company Announcements
Kezar Life Sciences Faces FDA Challenges in Drug Program
12M ago
8K
KZR
Kezar Life Sciences trading resumes
Premium
The Fly
Kezar Life Sciences trading resumes
12M ago
KZR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >